Answers are grounded in this paper and cite their sources.
Observational analysis explores high lipoprotein(a) and standard cardiovascular risk factors in coronary heart disease, suggesting potential therapeutic targets.
Lipoprotein (a) [Lp(a)] is a robust predictor of coronary heart disease outcomes, with targeted therapies currently under investigation. We aimed to evaluate the association of high Lp(a) with standard modifiable risk factors (SMuRFs) for incident first acute myocardial infarction (AMI).
No takes yet. Share an insight, caveat, or question.
Shiyovich et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: